Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says

Alzheimer's patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai and Biogen shows.

from US Top News and Analysis https://ift.tt/TFp6ZdS
https://ift.tt/IJ7y6K0